Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H17N3O3S |
| Molecular Weight | 331.389 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(C)C=NC(C[S@+]([O-])C2=NC3=C(N2)C=CC(O)=C3)=C1C
InChI
InChIKey=TWXDTVZNDQKCOS-QHCPKHFHSA-N
InChI=1S/C16H17N3O3S/c1-9-7-17-14(10(2)15(9)22-3)8-23(21)16-18-12-5-4-11(20)6-13(12)19-16/h4-7,20H,8H2,1-3H3,(H,18,19)/t23-/m0/s1
| Molecular Formula | C16H17N3O3S |
| Molecular Weight | 331.389 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:12:49 GMT 2023
by
admin
on
Sat Dec 16 05:12:49 GMT 2023
|
| Record UNII |
70LM138BBC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID10189416
Created by
admin on Sat Dec 16 05:12:49 GMT 2023 , Edited by admin on Sat Dec 16 05:12:49 GMT 2023
|
PRIMARY | |||
|
70LM138BBC
Created by
admin on Sat Dec 16 05:12:49 GMT 2023 , Edited by admin on Sat Dec 16 05:12:49 GMT 2023
|
PRIMARY | |||
|
358675-51-1
Created by
admin on Sat Dec 16 05:12:49 GMT 2023 , Edited by admin on Sat Dec 16 05:12:49 GMT 2023
|
PRIMARY | |||
|
29918914
Created by
admin on Sat Dec 16 05:12:49 GMT 2023 , Edited by admin on Sat Dec 16 05:12:49 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |
Metabolism of esomeprazole occurs via the hepatic CYP isoforms CYP2C19 and CYP3A4, which produce the 2 main pharmacologically inactive hydroxy and sulphone metabolites, respectively
MAJOR
|
||
|
PARENT -> METABOLITE INACTIVE |
|
